Funds and ETFs Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 CNY | -1.57% | -6.42% | -16.47% |
May. 28 | Hybio Pharmaceutical Gets Nod to Market Ganirelix Acetate Injection | MT |
May. 13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
ETFs positioned on Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 2 M€ | -18.79% | - | |
0.00% | 2,867 M€ | +5.89% | - | |
0.00% | 454 M€ | +4.02% | - | |
0.00% | 153 M€ | +3.74% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 7 M€ | +5.36% | - | |
0.00% | 15 M€ | +15.88% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.47% | 2.79B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 603707 Stock
- Funds and ETFs Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.